XML 32 R21.htm IDEA: XBRL DOCUMENT v3.21.2
Note O - Share-based Compensation
3 Months Ended
Jun. 27, 2021
Notes to Financial Statements  
Share-based Payment Arrangement [Text Block]

NOTE O – SHARE-BASED COMPENSATION

 

Total share-based compensation during the thirteen week periods ended June 27, 2021 and June 28, 2020 was $29,000. Total share-based compensation is included in general and administrative expenses in our accompanying Consolidated Statements of Earnings. As of June 27, 2021, there was $25,000 of unamortized compensation expense related to share-based incentive awards. We expect to recognize this expense over approximately two months, which represents the weighted average remaining requisite service periods for such awards.

 

The Company recognizes compensation cost for unvested stock-based incentive awards on a straight-line basis over the requisite service period. Compensation cost charged to expense under all stock-based incentive awards is as follows (in thousands):

                 

  Thirteen weeks ended 
  

June 27, 2021

  

June 28, 2020

 
         

Stock options

 $21  $21 

Restricted stock

  8   8 

Total compensation cost

 $29  $29 

 

Stock options:

 

There were no new share-based awards granted during the thirteen week period ended June 27, 2021.

 

Transactions with respect to stock options for the thirteen weeks ended June 27, 2021 are as follows:

 

      

Weighted-

  

Weighted-

  

Aggregate

 
      

Average

  

Average

  

Intrinsic

 
      

Exercise

  

Remaining

  

Value

 
  

Shares

  

Price

  

Contractual Life

  

(in thousands)

 
                 

Options outstanding at March 28, 2021

  10,000  $89.90   2.46   - 

Granted

  -   -   -   - 

Exercised

  -   -   -   - 

Options outstanding at June 27, 2021

  10,000  $89.90   2.21   - 
                 

Options exercisable at June 27, 2021

  6,667  $89.90   2.21   - 

 

Restricted stock:

 

Transactions with respect to restricted stock for the thirteen weeks ended June 27, 2021 are as follows:

 

      

Weighted-

 
      

Average

 
      

Grant-date

Fair value

 
  

Shares

  

Per share

 

Unvested restricted stock at March 28, 2021

  333  $89.90 

Granted

  -   - 

Vested

  -   - 

Unvested restricted stock at June 27, 2021

  333  $89.90